17th June is clean air day
Want to achieve a world with cleaner air? Learn more about the Global Action Plan to reduce air pollution at…
Heart & Lung
Scotland: Hope for patients with pulmonary fibrosis
The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…
Plastic device could reduce risks of treating heart disease
A plastic device that could radically reduce the risks and complications of treating coronary heart disease, is being co-developed by…
LISTEN TO YOUR HEART? It could save your life!
Do you LISTEN TO YOUR HEART? It could save your life! As part of World Heart Rhythm Week (7th-13th June), a…
DETECT AF at vaccine centres
DETECT AF at vaccine centres: Success of Arrhythmia Alliance Detection of AF at COVID-19 vaccination centres scheme shows value of…
Nanocapsules could reduce existing treatment’s side effects
Blood clot-busting nanocapsules could reduce existing treatment’s side effects: Imperial researchers have designed drug delivery nanocapsules that could reduce the…
Funding boost for vulnerable Australian cardiac patients
Funding boost gives hope to vulnerable Australian cardiac patients: A Curtin University research team has been awarded almost $1.5million in…
Results of the COLCORONA study
Results of the COLCORONA study published in The Lancet Respiratory Medicine - Colchicine could be considered as a treatment for…
Victory for thousands of terminally ill patients
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than…
WHO: Long working hours increasing deaths
Long working hours increasing deaths from heart disease and stroke: WHO, ILO: Long working hours led to 745 000 deaths…